A Phase I Dose-Escalation Study to Evaluate the Safety and Tolerability of Evofosfamide in Combination with Ipilimumab in Advanced Solid Malignancies.
Aparna HegdePriyamvada JayaprakashColine A CouillaultSarina Piha-PaulDaniel KarpJordi RodonShubham PantSiqing FuEcaterina E DumbravaTimothy Anthony YapVivek SubbiahPriya R BhosaleCristian CoarfaJack P HigginsEric T WilliamsThomas F WilsonJoAnn LimFunda Meric-BernstamElizabeth SumnerHira ZainDi NguyenLy M NguyenKimal RajapaksheMichael A CurranDavid S HongPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
No new or unexpected safety signals were observed from combining evofosfamide and ipilimumab, and evidence of therapeutic activity was noted.